Event Type
Disclosure
Mandatory
Variant
8-K
. Entry Into Material Definitive Agreement. Northwest Biotherapeutics, Inc. (OTCQB:NWBO) (the “Company” or “NWBio”), a biotechnology company developing DCVax ®